2022
DOI: 10.21037/aob-21-83
|View full text |Cite
|
Sign up to set email alerts
|

Noninfectious transfusion-associated adverse events

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Advancements in immunosuppressive drugs have played a pivotal role in mitigating immune reactions against non-ABO antigens in the perspective of organ transplantation [23]. These drugs are designed to moderate the recipient's immune response, thus dropping the hazard of graft rejection and improving the long-term existence of transplanted organs.…”
Section: Advancements In Immunosuppressive Drugsmentioning
confidence: 99%
“…Advancements in immunosuppressive drugs have played a pivotal role in mitigating immune reactions against non-ABO antigens in the perspective of organ transplantation [23]. These drugs are designed to moderate the recipient's immune response, thus dropping the hazard of graft rejection and improving the long-term existence of transplanted organs.…”
Section: Advancements In Immunosuppressive Drugsmentioning
confidence: 99%